在c-Abl的自身抑制
Helma Pluk1, Karel Dorey, Giulio Superti-Furga
1Developmental Biology Programme, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.
Cell
|February 8, 2002
概括
研究人员发现,c-Abl 铁氨酸激酶
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 在瘤学瘤学.
背景情况:
- 控制c-Abl氨酸激酶活性的精确分子机制一直是长期以来的一个研究问题.
- c-Abl的失调与各种癌症有关,特别是通过BCR-Abl融合蛋白的慢性髓性白血病.
研究的目的:
- 为了阐明c-Abl氨酸激酶的内在调节机制.
- 为了确定负责c-Abl自我调节的特定蛋白质域.
- 了解c-Abl调节在瘤发生和BCR-Abl放松调节中的作用.
主要方法:
- 在体外催化活性测定中使用纯化的c-Abl蛋白.
- 生物化学分析用于研究蛋白质与蛋白质相互作用.
- 对N-终端修改对c-Abl活动的功能影响的评估.
主要成果:
- 证明c-Abl具有内在的抑制能力,调节其自身的催化活性.
- 确定了N-终端80残留物作为一个关键的"上限"域调节自我调节.
- 表明,这种N端上限域的丧失导致瘤转化,并有助于BCR-Abl放松管制.
结论:
- 自主调节是c-Abl氨酸激酶的固有特性,由其N端域介导.
- 对于维持c-Abl抑制而言,N端盖是必不可少的.
- 这种调节上限的破坏是c-Abl瘤激活和BCR-Abl相关的白血病发生的关键事件.
相关概念视频
Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...


